Back to Bahl & Gaynor LLC Bahl & Gaynor LLC

LLYLLY

Showing 9 of 31 quarters

Position history for Bahl & Gaynor LLCBahl & Gaynor LLC's holdings in Eli Lilly and Company

Yes. Bahl & Gaynor holds 543,245 shares of LLY (Eli Lilly), worth $628.6M, as of its Q3 2026 13F filing. It reduced the position by 112,878 shares (-17.2%) from Q2 2026. Bahl & Gaynor has held LLY in every 13F on record since Q1 2019, 31 quarterly filings. LLY is 3.0% of Bahl & Gaynor's reported 13F portfolio.

Current Value

$628.6M

Current Shares

543,245

Total Value Change

-$136.5M

Total Shares Change

-320,353

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
543,245
-17.2%
$628.6M3.0%$1,157.08
0
2026-Q2
Decreased
656,123
-1.5%
$787M3.6%$1,197.71
0
2026-Q1
Decreased
666,129
-15.4%
$612.7M3.1%$916.88
0
2025-Q4
Decreased
787,380
-2.1%
$846.2M4.3%$1,069.51
0
2025-Q3
Decreased
803,980
-3.3%
$613.4M3.0%$758.22
0
2025-Q2
Decreased
831,489
-1.5%
$648.2M3.3%$772.95
0
2025-Q1
Decreased
844,400
-0.9%
$697.4M3.6%$817.26
0
2024-Q4
Decreased
851,890
-1.4%
$657.7M3.5%$762.60
0
2024-Q3
Decreased
863,598
-0.2%
$765.1M3.9%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used